April 04,2007
Grassley Seeks Marketing and Safety Documents from Major Drug Maker
WASHINGTON — Sen. Chuck Grassley is asking the drug maker, Eli Lilly and Company, for information related to the risks and marketing of the anti-psychotic drug Zyprexa. Grassley made this request in response to allegations that the company downplayed safety risks and engaged in other improper marketing practices that may be jeopardizing patients’ health.
The text of Grassley’s letter can be found in the printer-friendly version of this news release.
###
Next Article Previous Article
Recent News
- Wyden Continues Swiss Bank Investigation Following Indictment of American Credit Suisse Client on Tax Evasion Charges
- Wyden Urges Committee Approval of U.S. Tax Court Nominees
- Wyden Urges Senate Support for Tax Court Nominees
- Wyden, Senators Propose Criminal Penalties, Consumer Protections to Stop Rogue Health Insurance Brokers
- Wyden Statement on New Biden-Harris Administration Affordable Housing Initiative